London Company of Virginia’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $286K | Sell |
2,378
-1,491
| -39% | -$172K | ﹤0.01% | 159 |
|
|
2025
Q4 | $407K | Sell |
3,869
-850
| -18% | -$79.8K | ﹤0.01% | 161 |
|
|
2025
Q3 | $396K | Sell |
4,719
-1,475
| -24% | -$121K | ﹤0.01% | 161 |
|
|
2025
Q2 | $490K | Sell |
6,194
-8,648
| -58% | -$687K | ﹤0.01% | 156 |
|
|
2025
Q1 | $1.33M | Sell |
14,842
-2,152,170
| -99% | -$201M | 0.01% | 139 |
|
|
2024
Q4 | $216M | Sell |
2,167,012
-161,330
| -7% | -$16.6M | 1.18% | 37 |
|
|
2024
Q3 | $264M | Sell |
2,328,342
-169,750
| -7% | -$20.2M | 1.39% | 24 |
|
|
2024
Q2 | $309M | Sell |
2,498,092
-123,818
| -5% | -$15.9M | 1.74% | 18 |
|
|
2024
Q1 | $346M | Sell |
2,621,910
-104,038
| -4% | -$12.8M | 1.82% | 16 |
|
|
2023
Q4 | $297M | Sell |
2,725,948
-197,464
| -7% | -$20.5M | 1.67% | 20 |
|
|
2023
Q3 | $301M | Sell |
2,923,412
-108,757
| -4% | -$11.7M | 1.81% | 18 |
|
|
2023
Q2 | $350M | Sell |
3,032,169
-75,855
| -2% | -$8.61M | 1.98% | 11 |
|
|
2023
Q1 | $331M | Sell |
3,108,024
-99,335
| -3% | -$10.7M | 1.91% | 13 |
|
|
2022
Q4 | $356M | Buy |
3,207,359
+9,898
| +0.3% | +$1.01M | 2.1% | 13 |
|
|
2022
Q3 | $275M | Buy |
3,197,461
+111,272
| +4% | +$9.93M | 1.74% | 19 |
|
|
2022
Q2 | $281M | Sell |
3,086,189
-117,109
| -4% | -$10.4M | 1.72% | 18 |
|
|
2022
Q1 | $263M | Buy |
3,203,298
+113,778
| +4% | +$8.97M | 1.39% | 27 |
|
|
2021
Q4 | $237M | Sell |
3,089,520
-7,153
| -0.2% | -$570K | 1.19% | 34 |
|
|
2021
Q3 | $233M | Buy |
3,096,673
+85,396
| +3% | +$6.49M | 1.28% | 34 |
|
|
2021
Q2 | $234M | Sell |
3,011,277
-126,866
| -4% | -$9.44M | 1.25% | 35 |
|
|
2021
Q1 | $231M | Sell |
3,138,143
-2,668
| -0.1% | -$197K | 1.32% | 32 |
|
|
2020
Q4 | $245M | Buy |
3,140,811
+41,184
| +1% | +$3.15M | 1.53% | 25 |
|
|
2020
Q3 | $245M | Buy |
3,099,627
+9,948
| +0.3% | +$779K | 1.75% | 19 |
|
|
2020
Q2 | $228M | Buy |
3,089,679
+69,748
| +2% | +$5.25M | 1.77% | 20 |
|
|
2020
Q1 | $222M | Sell |
3,019,931
-114,084
| -4% | -$8.97M | 2.12% | 11 |
|
|
2019
Q4 | $272M | Sell |
3,134,015
-42,552
| -1% | -$3.5M | 2.1% | 10 |
|
|
2019
Q3 | $255M | Sell |
3,176,567
-19,006
| -0.6% | -$1.52M | 2.1% | 11 |
|
|
2019
Q2 | $256M | Buy |
3,195,573
+12,964
| +0.4% | +$993K | 2.2% | 9 |
|
|
2019
Q1 | $253M | Sell |
3,182,609
-35,282
| -1% | -$2.64M | 2.16% | 10 |
|
|
2018
Q4 | $235M | Sell |
3,217,891
-252,415
| -7% | -$17.8M | 2.24% | 9 |
|
|
2018
Q3 | $235M | Sell |
3,470,306
-69,638
| -2% | -$4.44M | 1.83% | 17 |
|
|
2018
Q2 | $205M | Sell |
3,539,944
-44,245
| -1% | -$2.5M | 1.67% | 19 |
|
|
2018
Q1 | $186M | Sell |
3,584,189
-347,989
| -9% | -$18.8M | 1.49% | 27 |
|
|
2017
Q4 | $211M | Sell |
3,932,178
-397,063
| -9% | -$22M | 1.53% | 25 |
|
|
2017
Q3 | $265M | Sell |
4,329,241
-103,295
| -2% | -$6.26M | 1.9% | 13 |
|
|
2017
Q2 | $271M | Buy |
4,432,536
+146,539
| +3% | +$8.92M | 1.84% | 13 |
|
|
2017
Q1 | $260M | Buy |
4,285,997
+229,381
| +6% | +$13.9M | 1.71% | 13 |
|
|
2016
Q4 | $228M | Buy |
4,056,616
+537,631
| +15% | +$31.5M | 1.57% | 19 |
|
|
2016
Q3 | $210M | Buy |
3,518,985
+312,654
| +10% | +$18.3M | 1.57% | 20 |
|
|
2016
Q2 | $176M | Buy |
3,206,331
+313,215
| +11% | +$16.7M | 1.36% | 27 |
|
|
2016
Q1 | $146M | Buy |
2,893,116
+2,879,581
| +21,275% | +$141M | 1.2% | 38 |
|
|
2015
Q4 | $682K | Sell |
13,535
-681
| -5% | -$34.3K | 0.01% | 113 |
|
|
2015
Q3 | $670K | Sell |
14,216
-383
| -3% | -$20.3K | 0.01% | 114 |
|
|
2015
Q2 | $793K | Buy |
+14,599
| New | +$819K | 0.01% | 108 |
|
Other funds holding MRK
VCM
VPM
London Company of Virginia's MRK Position: Q1 2026 in Review
London Company of Virginia reduced its Merck (MRK) stake by 39% in Q1 2026, selling an estimated $172K and leaving 2,378 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #159.
London Company of Virginia first reported a position in MRK in Q2 2015 and has held it in 44 quarters since. The position peaked at $356M in Q4 2022. 3,790 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- London Company of Virginia held 2,378 shares of Merck worth $286K as of Q1 2026.
- London Company of Virginia sold 1,491 Merck shares in Q1 2026, an estimated $172K.
- Merck made up ﹤0.01% of London Company of Virginia's portfolio in Q1 2026, its #159 holding.
- London Company of Virginia first reported a position in Merck in Q2 2015 and has held it in 44 quarters since.
- London Company of Virginia's Merck position peaked at $356M in Q4 2022.
- 3,790 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on London Company of Virginia's 13F filing for Q1 2026, filed 15 May 2026.